UTTLESFORD HEALTH LIMITED

Registered office: CMB Partners UK Ltd, 49 Tabernacle Street, London, EC2A 4AA

Principal trading address: 5 Ferguson Close, Radwinter Road, Saffron Walden, Essex, CB11 3HY

Notice is hereby given, pursuant to Rule 14.28 of the Insolvency (England and Wales) Rules 2016, that the Joint Liquidators intend to declare a first and final dividend to ordinary unsecured creditors of the Company within the period of two months from the last date for proving specified below.

Creditors who have not yet done so must prove their debts by delivering their proofs (in the format specified in Rule 14.4) to the Liquidators at CMB Partners UK Ltd, 49 Tabernacle Street, London, EC2A 4AA by no later than 25 November 2025 (the last date for proving).

Creditors who have not proved their debt by the last date for proving may be excluded from the benefit of this dividend or any other dividend declared before their debt is proved.

In accordance with the provisions of Part 14 of the Insolvency (England and Wales) Rules 2016, a creditor whose debt is a 'small debt' not exceeding £1,000 is deemed to have proved for the purposes of determination and payment of this dividend and is not required to prove their debt as described by this notice unless advised otherwise by the Joint Liquidators.

Date of Appointment: 18 December 2023

Office Holder Details: Lane Bednash (IP No. 8882) and Adam Price (IP No. 25050) both of CMB Partners UK Limited, 49 Tabernacle Street, London, EC2A 4AA

Further details contact: The Joint Liquidators, Email: info@cmbukltd.co.uk. Tel: 020 7377 4370. Alternative contact: Safa Riaz.

Adam Price, Joint Liquidator

17 October 2025

Ag HK71964